Long‐Term Corticosteroid‐Sparing Immunosuppression for Cardiac Sarcoidosis

BACKGROUND: Long‐term corticosteroid therapy is the standard of care for treatment of cardiac sarcoidosis (CS). The efficacy of long‐term corticosteroid‐sparing immunosuppression in CS is unknown. The goal of this study was to assess the efficacy of methotrexate with or without adalimumab for long‐t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenthal, David G., Parwani, Purvi, Murray, Tyler O., Petek, Bradley J., Benn, Bryan S., De Marco, Teresa, Gerstenfeld, Edward P., Janmohamed, Munir, Klein, Liviu, Lee, Byron K., Moss, Joshua D., Scheinman, Melvin M., Hsia, Henry H., Selby, Van, Koth, Laura L., Pampaloni, Miguel H., Zikherman, Julie, Vedantham, Vasanth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818011/
https://www.ncbi.nlm.nih.gov/pubmed/31538835
http://dx.doi.org/10.1161/JAHA.118.010952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818011/
https://www.ncbi.nlm.nih.gov/pubmed/31538835
http://dx.doi.org/10.1161/JAHA.118.010952

Ejemplares similares